The main objective of the study is to evaluate the presence of Early Vascular Aging (EVA) 3-6 months and 12-15 months after COVID-19 infection. The primary endpoint will be carotid-femoral pulse wave velocity (PWV), an established biomarker of EVA .
Posting date: Fri, 07/03/2020
Award start date: Tue, 09/01/2020
Award end date: Wed, 08/31/2022
